Advertisement

Topics

Companies Related to "A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937 Am1)(COMPLETED)" [Most Relevant Company Matches] RSS

14:59 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937 Am1)(COMPLETED)" found in our extensive corporate database of over 50,000 company records.

Showing "Trial Determine Whether Differing Strength Tablets Versus Sublingually" Companies 1–25 of 1,200+

Relevant

CIMA LABS INC

CIMA LABS INC. is a drug delivery technology company. We develop and manufacture prescription and over-the-counter medication based on proprietary, orally disintegrating technologies (also referred to as fast dissolve, fast melt and fast disintegrating). OraSolv® and DuraSolv® orally disintegrating tablets (ODTs) disperse quickly in the mouth without chewing or the need for water - making it eas...


Iinvivodata

invivodata is the worldwide leader in capturing clinical trial data of the highest integrity directly from patients. With a unique combination of scientific, technological, and regulatory expertise, invivodata has pioneered the evolution of the electronic Patient Reported Outcomes (ePRO) industry and continues to provide innovative methods that make it easy for clinical trial sponsors to attain th...

NextPharma Technologies

Profile NextPharma is one of the leading contract manufacturers in Europe for the pharmaceutical and health care industries. We offer both conventional technologies and specialist technologies across the major European markets. We can offer a full service package including: Product Development Manufacturing and packaging Logisticsand accompanying services such as Analytics Microbiological testing ...


Purdue Products L.P. Line of Laxatives

Senokot® Tablets and Colace® Capsules have been recommended by doctors and pharmacists for more than 50 years for effective, gentle and safe relief from occasional constipation. Colace® Capsules, the #1 recommended stool softener brand by doctors and pharmacists, relieves occasional constipation that may be associated with certain medical conditions. Senokot-S® Tablets provide gentle, yet effe...

Procter & Gamble Pharmaceuticals

Three billion times a day, P&G brands touch the lives of people around the world. P&G has one of the strongest portfolios of trusted, quality, leadership brands, including Actonel(R) (risedronate sodium) tablets, Asacol(R) (mesalamine) delayed-release tablets, Asacol(R) HD (mesalamine) delayed-release tablets, Enablex(R) (darifenacin) extended release tablets, Prilosec OTC(R), Align(R), Metamucil(...

Tablets & Capsules

Tablets & Capsules is the only technical publication devoted exclusively to readers in the tablet and capsule processing industries.

Soligenix, Inc.

Soligenix, Inc. (Soligenix) is a late-stage biopharmaceutical company developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Soligenix's lead product, orBec(®) (oral beclomethasone dipropionate or BDP), is a potent, locally acting corticosteroid being developed for the treatment of acute ...

NeoMatrix, LLC

Based in Irvine, Calif., NeoMatrix© develops innovative devices that allow women and their doctors to promote optimal breast health. The company's premier product, the HALO Breast Pap Test System, is the first fully automated, noninvasive breast cancer risk assessment tool designed for use in the primary care office setting. The System has been FDA cleared for the collection of nipple aspirate fl...

ERWEKA GmbH

ERWEKA is a private owned internationally operating group with more than 100 employees existing for more than 50 years.ERWEKA is one of the leading manufacturers of All Purpose and Pharmaceutical Testing Equipment for solid dosage forms e.g. tablets, capsules, coated tablets etc. and has a distinguished record for high quality products, reliability and excellent customer service.

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

CureDuchenne

CureDuchenne is a nonprofit organization that raises awareness and funds specifically aimed at taking on Duchenne Muscular Dystrophy (DMD). By working closely with the world’s leading DMD scientists CureDuchenne works to determine the most viable research projects that will accelerate the clinical trial process and bring potential life saving drugs to...

Xplore Technologies Corp.

Xplore Technologies Corp. has been a leading global provider of truly rugged tablets since 1998. With nearly 90,000 deployments, Xplore tablets are among the most powerful and longest lasting in their class, withstand nearly any hazardous condition or environmental extreme, and feature competitive pricing and significant ROI. The company's products are sol...

Santarus, Inc. and Depomed, Inc.

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. The company's current commercial efforts are focused on GLUMETZA® (metformin hydrochloride extended release tablets) and CYCLOSET® (bromocriptine mesylat...

Santarus, Inc. & Depomed, Inc.

Santarus, Inc. is a specialty biopharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by physician specialists. The company’s current commercial efforts are focused on GLUMETZA® (metformin hydrochloride extended release tablets) and CYCLOSET® (bromocriptine me...

Trial By Fire Solutions

Trial By Fire Solutions is a global leader in web-based clinical trial management solutions and develops innovative applications to improve planning, execution and tracking of clinical studies. Since the release of its SimpleCTMS product, Trial By Fire Solutions has been providing affordable eClinical solutions to teams of all sizes.

GMP Genetics

GMP Conversion Technology™ is a diploid to haploid sample preparation process that separates genes into two differing natural forms as inherited from each parent. Published studies suggest that genetic testing on haploid samples detects abnormalities associated with certain hereditary diseases nearly 100% of the time

Provisio, Inc

Headquartered in Nashville, TN, Provisio, Inc. develops technologies and services that enhance clinical trial processes. Its flagship solution, iTrials, automates and streamlines the way drug trial candidates are identified, notified and enrolled. iTrials breaks the traditional paradigm associated with lengthy and costly clinical trial enrollment. Leveraging iTrials "unique-to-industry" data wareh...

RealTime Laboratories, LLC

RealTime Laboratories, LLC (RTL) is a molecular biology and microbiology laboratory specializing in the detection of mycotoxins in human and environmental samples. RTL uses patented DNA testing to help patients and their physicians determine the effects of exposure to environmental toxins. To date, RTL has conducted the only peer reviewed and published research on the subject of contaminated drywa...

Trial Acceleration Institute, Inc.

Trial Acceleration Institute collaborates with the entire spectrum of clinical trial stakeholders to improve study cycle times. Assisting stakeholders with actionable resolutions to their specific cycle time challenges (from protocol feasibility to patient retention) via the identification and initiation of best-of-class, third-party solutions is the primary mission of Trial Acceleration Institute...

MaaT Pharma

MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leuk...

Wearable Technology Show

“The Wearable Technology Show continues to grow from strength to strength, breaking new boundaries in terms of our global audience, reach and content each year,” commented COO John Weir.

Sonitor Technologies Inc.

Sonitor® is the leading provider and innovator of accurate and reliable ultrasound-based Real Time Location Systems (RTLS) and Indoor Positioning Systems (IPS). As the first and only company to use proprietary ultrasound technology as the primary technology for indoor positioning, Sonitor’s Sense™ and Forkbeard™ platforms work seamlessly ...

Acura Pharmaceuticals

Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on research and development of our proprietary Aversion® (abuse deterrent) Technology and related product candidates. Aversion® Technology can be formulated into orally administered tablets or capsules containing active pharmaceutical ingredients including oxycodone, hydrocodone, hydromorphone, oxymorphone, morphine, code...

The Dent Law Firm

Dwain Dent found The Dent Law Firm in 1990. Dent has been recognized as a Texas Superlawyer by Texas Monthly Magazine and as one of the Top 100 Trial Lawyers by the American Trial Lawyers Association. He is board certified in personal injury trial work by the Texas Board of Legal Specialization, the State Bar of Texas and the National Board of Trial Advocacy.

Valentis

Valentis is a biotechnology company that was engaged in the development of innovative products for peripheral arterial disease (PAD), a large and unsatisfied market. On July 11, 2006 Valentis announced that no statistically significant difference was seen in the primary endpoint or any of the secondary endpoints in its Phase IIb clinical trial of VLTS 934 in PAD. The primary efficacy endpoint in t...


More From BioPortfolio on "A Trial to Determine Whether Two Differing Strength Tablets (3 x 5 mg Versus 1 x 15 mg) of Sublingually Org 5222 Are Safe and Equal in Subjects With Schizophrenia or Schizoaffective Disorder (P05937 Am1)(COMPLETED)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks